Healthcare stocks are in focus on Friday, 20 November, even as broader equity markets remained under pressure. Shares of Molbio Diagnostics, Apollo Hospitals Enterprise and Aster DM Quality Care rose up to 4%, drawing investor attention to the hospital and healthcare space.
The rally in hospital stocks comes after global brokerage Macquarie turned more constructive on the sector, upgrading Apollo Hospitals and Max Healthcare to 'Outperform' from 'Underperform'. The brokerage cited improving earnings prospects, more reasonable valuations and signs that the earnings pressure from the ongoing hospital capacity expansion cycle may be easing, according to media reports.
With newly commissioned beds ramping up at a healthy pace and consensus earnings estimates for the sector appearing to have bottomed out, Macquarie believes the risk-reward equation for select hospital stocks has improved.
According to media reports, Macquarie raised its price target on Apollo Hospitals to ₹10,500 from ₹6,230, implying an upside of around 20% from Thursday's closing price.
The brokerage believes the initial impact on profitability from the hospital industry's expansion cycle is already reflected in valuations. It also expects newly added capacity to contribute more meaningfully as hospitals improve utilisation.